Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro

European Journal of Gynaecological Oncology

Volumn 27, Issue 3, 2006, Pages 243-246

  Tanaka, T ^a   Yukawa, K ^a   Umesaki, N ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Cervical cancer; Chemoradiotherapy; Radiosensitivity; Radiosensitizer; Squamous cell carcinoma

Indexed keywords

FLUOROURACIL;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GAMMA RADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; RADIATION DOSE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; FEMALE; FLAP ENDONUCLEASES; FLUOROURACIL; GAMMA RAYS; HUMANS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 33745453804     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Christie D.R., Bull C.A., Gebski V., Langlands A.O.: "Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer". Radiother. Oncol., 1995, 37, 181.
2. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C. Jr., et al.: "Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southeast Oncology Group Study". J. Clin. Oncol., 1999, 17, 1339.
3. Lorvidhaya V., Chitapanarux I., Sangruchi S., Lertsanguansinchai P., Kongthanarat Y., Tangkaratt S., Visetsiri E.: "Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial". Int. J. Rad. Oncol. Biol. Phys., 2003, 55, 1226.
4. Tabata T., Takeshima N., Nishida H., Hirai Y., Hasumi K.: "A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix". Anticancer Res., 2003, 23, 2885.
5. Rakovitch E., Fyles A.W., Pintilie M., Leung P.M.: "Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix". Int. J. Rad. Oncol. Biol. Phys., 1997, 38, 979.
6. Yamamoto K., Izumi R., Hasegawa K., Nakajjima H., Ohashi K., Kubo R. et al.: "Adjuvant oral 5-fluorouracil for cervical cancer: Japanese Gynecologic Oncology Group report". Int. J. Oncol., 2004, 24, 1175.
7. Lancillotti, F., Giandomenico, V., Affabris, E., Fiorucci, G., Romeo, G., Rossi G.B.: "Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells". Cancer Res., 1995, 55, 3158.
8. Saxena A., Yashar C., Taylor D.D., Gercel-Taylor C.: "Cellular response to chemotherapy and radiation in cervical cancer". Am. J. Obstet. Gynecol., 2005, 192, 1399.